References of "Schoenen, Jean"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailTranscranial Direct Current Stimulation (tDCS) of the visual cortex: a proof-of-concept study based on interictal electrophysiological abnormalities in migraine
Vigano, Alessandro; Sasso d'Elia, Tullia; SAVA, Simona Liliana ULg et al

in Journal of Headache & Pain (2013), 14(23),

Detailed reference viewed: 57 (4 ULg)
Full Text
Peer Reviewed
See detailLateral inhibition in visual cortex of migraine patients between attacks
Coppola, Gianluca; Parisi, Vincenzo; Di Lorenzo, Cherubino et al

in Journal of Headache & Pain (2013), 14

Detailed reference viewed: 23 (1 ULg)
Full Text
Peer Reviewed
See detailMigraine prevention with a supraorbital transcutaneous stimulator. A randomized controlled trial.
Schoenen, Jean ULg; Vandersmissen, Bart; Jeangette, Sandrine et al

in Neurology (2013), 80

Detailed reference viewed: 96 (3 ULg)
Full Text
Peer Reviewed
See detail(31) P-MRS in migraine: fallen through the cracks.
SCHOENEN, Jean ULg; Paemeleire, Koen

in Headache (2013), 53(4), 676-678

This commentary highlights the neglected (31) P-MR spectroscopy studies in migraine patients between attacks showing decreased ATP levels in the brain.

Detailed reference viewed: 17 (0 ULg)
Full Text
Peer Reviewed
See detailAlexithymia and empathy predict changes in autonomic arousal during affective stimulation
Bogdanov, V; Bogdanova, O; Gorlov, DS et al

in Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology (2013), 26(3), 121-132

Detailed reference viewed: 14 (0 ULg)
Full Text
Peer Reviewed
See detailHabituation and sensitization in primary headaches.
Coppola, Gianluca; Di Lorenzo, CM; SCHOENEN, Jean ULg et al

in Journal of Headache & Pain (2013), 14(1), 65

Detailed reference viewed: 10 (1 ULg)
Full Text
Peer Reviewed
See detailQuadripulse Repetitive Transcranial Magnetic Stimulation on Visual Cortex for Chronic Migraine Prevention: A Pilot-Trial
Sasso d'Elia, Tullia; Vigano, Alessandro; Fataki, Michel et al

in Cephalalgia : An International Journal of Headache (2013), 33(8), 49

Detailed reference viewed: 43 (1 ULg)
Full Text
Peer Reviewed
See detailConditioned Medium from Bone marrow-derived Mesenchymal Stem Cells improves recovery after Spinal Cord Injury in rats: an original strategy to avoid cell transplantation.
CANTINIEAUX, Dorothée ULg; QUERTAINMONT, Renaud; BLACHER, Silvia ULg et al

in PLoS ONE (2013), 8(8), 69515

Spinal cord injury triggers irreversible loss of motor and sensory functions. Numerous strategies aiming at repairing the injured spinal cord have been studied. Among them, the use of bone marrow-derived ... [more ▼]

Spinal cord injury triggers irreversible loss of motor and sensory functions. Numerous strategies aiming at repairing the injured spinal cord have been studied. Among them, the use of bone marrow-derived mesenchymal stem cells (BMSCs) is promising. Indeed, these cells possess interesting properties to modulate CNS environment and allow axon regeneration and functional recovery. Unfortunately, BMSC survival and differentiation within the host spinal cord remain poor, and these cells have been found to have various adverse effects when grafted in other pathological contexts. Moreover, paracrine-mediated actions have been proposed to explain the beneficial effects of BMSC transplantation after spinal cord injury. We thus decided to deliver BMSC-released factors to spinal cord injured rats and to study, in parallel, their properties in vitro. We show that, in vitro, BMSC-conditioned medium (BMSC-CM) protects neurons from apoptosis, activates macrophages and is pro-angiogenic. In vivo, BMSC-CM administered after spinal cord contusion improves motor recovery. Histological analysis confirms the pro-angiogenic action of BMSC-CM, as well as a tissue protection effect. Finally, the characterization of BMSC-CM by cytokine array and ELISA identified trophic factors as well as cytokines likely involved in the beneficial observed effects. In conclusion, our results support the paracrine-mediated mode of action of BMSCs and raise the possibility to develop a cell-free therapeutic approach. [less ▲]

Detailed reference viewed: 60 (11 ULg)
Full Text
Peer Reviewed
See detailStimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: A randomized, sham-controlled study.
Schoenen, Jean ULg; Jensen, Rigmor Hojland; Lanteri-Minet, Michel et al

in Cephalalgia : An International Journal of Headache (2013)

BackgroundThe pain and autonomic symptoms of cluster headache (CH) result from activation of the trigeminal parasympathetic reflex, mediated through the sphenopalatine ganglion (SPG). We investigated the ... [more ▼]

BackgroundThe pain and autonomic symptoms of cluster headache (CH) result from activation of the trigeminal parasympathetic reflex, mediated through the sphenopalatine ganglion (SPG). We investigated the safety and efficacy of on-demand SPG stimulation for chronic CH (CCH).MethodsA multicenter, multiple CH attack study of an implantable on-demand SPG neurostimulator was conducted in patients suffering from refractory CCH. Each CH attack was randomly treated with full, sub-perception, or sham stimulation. Pain relief at 15 minutes following SPG stimulation and device- or procedure-related serious adverse events (SAEs) were evaluated.FindingsThirty-two patients were enrolled and 28 completed the randomized experimental period. Pain relief was achieved in 67.1% of full stimulation-treated attacks compared to 7.4% of sham-treated and 7.3% of sub-perception-treated attacks (p < 0.0001). Nineteen of 28 (68%) patients experienced a clinically significant improvement: seven (25%) achieved pain relief in >/=50% of treated attacks, 10 (36%), a >/=50% reduction in attack frequency, and two (7%), both. Five SAEs occurred and most patients (81%) experienced transient, mild/moderate loss of sensation within distinct maxillary nerve regions; 65% of events resolved within three months.InterpretationOn-demand SPG stimulation using the ATI Neurostimulation System is an effective novel therapy for CCH sufferers, with dual beneficial effects, acute pain relief and observed attack prevention, and has an acceptable safety profile compared to similar surgical procedures. [less ▲]

Detailed reference viewed: 25 (2 ULg)
Full Text
Peer Reviewed
See detailBehavior in the open field predicts the number of KCl-induced cortical spreading depressions in rats.
Bogdanov, Volodymyr Borysovych; Bogdanova, Olena Viktorivna; Koulchitsky, Stanislav ULg et al

in Behavioural Brain Research (2013), 236(1), 90-3

Anxiety disorders are known to be comorbid with migraine, and cortical spreading depression (CSD) is the most likely cause of the migraine aura. To search for possible correlations between susceptibility ... [more ▼]

Anxiety disorders are known to be comorbid with migraine, and cortical spreading depression (CSD) is the most likely cause of the migraine aura. To search for possible correlations between susceptibility to CSD and anxiety we used the open field test in male Sprague-Dawley rats chronically treated with the preventive anti-migraine drugs valproate or riboflavin. Animals avoiding the central area of the open field chamber and those with less exploratory activity (i.e. rearing) were considered more anxious. After 4 weeks of treatment CSDs were elicited by application of 1M KCl over the occipital cortex and the number of CSDs occurring over a 2h period was compared to the previously assessed open field behavior. Higher anxiety-like behavior was significantly correlated with a higher frequency of KCl-induced CSDs. In saline-treated animals, fewer rearings were found in animals with more frequent CSDs (R=-1.00). The duration of ambulatory episodes in the open field center correlated negatively with number of CSDs in the valproate group (R=-0.83; p<0.005) and in riboflavin treated group (R=-0.69; p<0.05) as well as total time spent in the open field center in both groups (R=-0.75; p<0.05 and R=-0.58; p<0.1 respectively). These results suggest that anxiety symptoms are associated with susceptibility to CSD and might explain why it can be an aggravating factor in migraine with aura. [less ▲]

Detailed reference viewed: 24 (5 ULg)
Full Text
See detailAcetylation and Wallerian degeneration
Boerboom, Angélique ULg; Chaballe, Linda; Close, Pierre ULg et al

Poster (2012, October)

Detailed reference viewed: 19 (3 ULg)
Full Text
Peer Reviewed
See detailAnodal transcranial direct current stimulation over the visual cortex as a preventive treatment of migraine: a proof-of-concept study.
Sasso d'Elia, Tullia; Vigano, Alessandro; SAVA, Simona Liliana ULg et al

in Frontiers in Human Neuroscience (2012, September)

Detailed reference viewed: 36 (2 ULg)